These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8360181

  • 1. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator.
    Moser TL, Enghild JJ, Pizzo SV, Stack MS.
    J Biol Chem; 1993 Sep 05; 268(25):18917-23. PubMed ID: 8360181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assignment of the binding site for tissue plasminogen activator on human fibronectin.
    Wang L, Lin XH, Cui DF, Wang ZY, Chi CW.
    J Biol Chem; 1994 Feb 11; 269(6):4332-6. PubMed ID: 8308001
    [Abstract] [Full Text] [Related]

  • 4. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS, Pizzo SV.
    J Biol Chem; 1993 Sep 05; 268(25):18924-8. PubMed ID: 8360182
    [Abstract] [Full Text] [Related]

  • 5. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL, Enghild JJ, Pizzo SV, Stack MS.
    Biochem J; 1995 May 01; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [Abstract] [Full Text] [Related]

  • 6. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase.
    Marchina E, Barlati S.
    Int J Biochem Cell Biol; 1996 Oct 01; 28(10):1141-50. PubMed ID: 8930138
    [Abstract] [Full Text] [Related]

  • 7. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs.
    Maas C, Schiks B, Strangi RD, Hackeng TM, Bouma BN, Gebbink MF, Bouma B.
    Amyloid; 2008 Sep 01; 15(3):166-80. PubMed ID: 18925455
    [Abstract] [Full Text] [Related]

  • 8. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
    Kost C, Benner K, Stockmann A, Linder D, Preissner KT.
    Eur J Biochem; 1996 Mar 01; 236(2):682-8. PubMed ID: 8612645
    [Abstract] [Full Text] [Related]

  • 9. Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin.
    Hocking DC, Sottile J, McKeown-Longo PJ.
    J Biol Chem; 1994 Jul 22; 269(29):19183-7. PubMed ID: 8034677
    [Abstract] [Full Text] [Related]

  • 10. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH, Nieuwenbroek NM, Verheijen JH.
    Protein Eng; 1995 Dec 22; 8(12):1295-1302. PubMed ID: 8869642
    [Abstract] [Full Text] [Related]

  • 11. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS, Pizzo SV.
    Arch Biochem Biophys; 1994 Feb 15; 309(1):117-22. PubMed ID: 8117101
    [Abstract] [Full Text] [Related]

  • 12. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
    Stack MS, Gray RD, Pizzo SV.
    Cancer Res; 1993 May 01; 53(9):1998-2004. PubMed ID: 8481902
    [Abstract] [Full Text] [Related]

  • 13. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins.
    van der Hoek YY, Sangrar W, Côté GP, Kastelein JJ, Koschinsky ML.
    Arterioscler Thromb; 1994 Nov 01; 14(11):1792-8. PubMed ID: 7947605
    [Abstract] [Full Text] [Related]

  • 14. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS, Zeng Z, Walz DA.
    Arch Biochem Biophys; 1992 Sep 01; 297(2):271-6. PubMed ID: 1497347
    [Abstract] [Full Text] [Related]

  • 15. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH, Lee HJ, Lee EK, Yu HK, Lee TH, Yoon Y, Kim SJ, Kim JS.
    Biol Chem; 2011 Apr 01; 392(4):347-56. PubMed ID: 21194375
    [Abstract] [Full Text] [Related]

  • 16. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R, Geiger M, de Vries C, Pannekoek H, Binder BR.
    J Biol Chem; 1991 Feb 05; 266(4):2227-32. PubMed ID: 1824940
    [Abstract] [Full Text] [Related]

  • 17. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
    Steffensen B, Wallon UM, Overall CM.
    J Biol Chem; 1995 May 12; 270(19):11555-66. PubMed ID: 7744795
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ, Fredenburgh JC, Weitz JI.
    J Biol Chem; 1998 Jul 17; 273(29):18292-9. PubMed ID: 9660794
    [Abstract] [Full Text] [Related]

  • 19. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML.
    Chem Phys Lipids; 1994 Jan 17; 67-68():369-80. PubMed ID: 8187237
    [Abstract] [Full Text] [Related]

  • 20. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
    Tsurupa G, Ho-Tin-Noé B, Anglés-Cano E, Medved L.
    J Biol Chem; 2003 Sep 26; 278(39):37154-9. PubMed ID: 12853452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.